Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field.
January 02, 2025
Renew your membership for 2025 if you have not already done so to stay connected to our global community. Keep access to your member-exclusive resources, including discounts to our annual meetings, such as ENDO 2025 taking place in San Francisco, CA, USA, July 12-15, and exclusive networking and professional development opportunities.
January 16, 2025
Don’t miss your chance to celebrate excellence in endocrinology! The Laureate Awards recognize peers for groundbreaking research, exceptional clinical care, leadership, mentorship, and international contributions. Submit your nominations by January 21, 2025. Honor a colleague today!
January 16, 2025
The Editors-in-Chief extend their thanks to the innovative authors and expert peer reviewers who contributed insights to the success of the journals in 2024. Their contributions will extend scientific understanding and medical possibilities in endocrinology.
January 14, 2025
There is no better place to share your research than ENDO. Taking place July 12-15 in San Francisco, CA, ENDO 2025 will feature thousands of scientific presentations. Submitting an abstract for presentation at ENDO earns media coverage for your work, connects you with scientific investigators with similar interests, and helps drive future research.
January 17, 2025
The Society continues to work to advance our policy priorities, including recently sending a letter to the incoming Trump Administration urging them to finalize a rule the Biden Administration issued in November that would allow Medicare to cover anti-obesity medications for weight loss.
Need more info?
Learn more about the advantages of membership
December 10, 2024
Early life exposure to a class of endocrine-disrupting chemicals (EDCs) called polychlorinated biphenyls (PCBs) may lead to behavioral problems in rats, according to a new animal study published in the Journal of the Endocrine Society.
November 12, 2024
Vitamin D supplements may lower blood pressure in older people with obesity and taking more than the Institutes of Medicine’s (IOM) recommended daily dose does not provide additional health benefits, according to new research published in the Journal of the Endocrine Society.
November 06, 2024
Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications.
January 14, 2025
The authors report a 35-year-old woman who presented with secondary amenorrhea and prominent features of hyperandrogenism, including acne vulgaris, male-pattern alopecia, deepening of voice, and hirsutism.
January 14, 2025
This work aims to determine whether supplementation with vitamin D3 or omega-3 fatty acids vs placebo for 2 years improves physical performance measures.
January 14, 2025
In the present study, we show for the first time that increased circulating FGF23 levels in obese humans correlate with increased expression of adipose Fgf23 and both positively correlate with BMI.
